Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Muwaffak Alosman, Linghui Cao, Isaac Yaw Massey & Fei Yang. (2021) The lethal effects and determinants of microcystin-LR on heart: a mini review. Toxin Reviews 40:4, pages 517-526.
Read now
Read now
Roopesh Kansara & Kerry J. Savage. (2014) The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma. Leukemia & Lymphoma 55:4, pages 727-729.
Read now
Read now
Kristen Ganjoo, Fangxin Hong, Sandra J. Horning, Randy D. Gascoyne, Yasodha Natkunam, Lode J. Swinnen, Thomas M. Habermann, Brad S. Kahl & Ranjana H. Advani. (2014) Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leukemia & Lymphoma 55:4, pages 768-772.
Read now
Read now
Francine M. Foss, Nelida Sjak-Shie, Andre Goy, Eric Jacobsen, Ranjana Advani, Mitchell R. Smith, Rami Komrokji, Kelly Pendergrass & Vanessa Bolejack. (2013) A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study. Leukemia & Lymphoma 54:7, pages 1373-1379.
Read now
Read now
Articles from other publishers (19)
Michelle Koifman, Waqqas Tai, Daniel Castro, Amith Ahluwalia & Yingxian Liu. (2023) A Case of Angioimmunoblastic T-Cell Lymphoma and the Difficulties of Diagnosis. Cureus.
Crossref
Crossref
Takayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, Kentaro Fujimoto, Sae Yumita, Takamasa Ishino, Keita Ogawa, Terunao Iwanaga, Keisuke Koroki, Hiroaki Kanzaki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Sadahisa Ogasawara, Shingo Nakamoto, Tetsuhiro Chiba, Jun Kato & Naoya Kato. (2023) Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients. Scientific Reports 13:1.
Crossref
Crossref
Diana Xochiquetzal Robledo-Cadena, Juan Carlos Gallardo-Pérez, Víctor Dávila-Borja, Silvia Cecilia Pacheco-Velázquez, Javier Alejandro Belmont-Díaz, Stephen John Ralph, Betsy Alejandra Blanco-Carpintero, Rafael Moreno-Sánchez & Sara Rodríguez-Enríquez. (2020) Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells. Pharmaceuticals 13:12, pages 463.
Crossref
Crossref
Preethi Ramachandran, Alok Aggarwal & Jen Chin Wang. 2019. Peripheral T-cell Lymphomas. Peripheral T-cell Lymphomas.
Jin-Hua Liang, Luo Lu, Hua-Yuan Zhu, Wang Li, Lei Fan, Jian-Yong Li & Wei Xu. (2019) The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. Cancer Research and Treatment 51:1, pages 150-157.
Crossref
Crossref
John S. Van Arnam, Megan S. Lim & Kojo S. J. Elenitoba-Johnson. (2018) Novel insights into the pathogenesis of T-cell lymphomas. Blood 131:21, pages 2320-2330.
Crossref
Crossref
Nicole S. Klee, Cameron G. McCarthy, Patricia Martinez-Quinones & R. Clinton Webb. (2017) Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy. Therapeutic Advances in Cardiovascular Disease 11:11, pages 297-317.
Crossref
Crossref
Yuhei Shibata, Takeshi Hara, Senji Kasahara, Toshiki Yamada, Michio Sawada, Ryoko Mabuchi, Takuro Matsumoto, Nobuhiko Nakamura, Hiroshi Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Nobuhiro Kanemura, Yusuke Kito, Naoe Goto, Tatsuhiko Miyazaki, Tsuyoshi Takami, Tamotsu Takeuchi, Masahito Shimizu & Hisashi Tsurumi. (2015) CHOP or THP‐COP regimens in the treatment of newly diagnosed peripheral T‐cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin. Hematological Oncology 35:2, pages 163-171.
Crossref
Crossref
Matthew A. Lunning & Julie M. Vose. (2017) Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood 129:9, pages 1095-1102.
Crossref
Crossref
Ranjana H. Advani, Stephen M. Ansell, Mary J. Lechowicz, Anne W. Beaven, Fausto Loberiza, Kenneth R. Carson, Andrew M. Evens, Francine Foss, Steven Horwitz, Barbara Pro, Lauren C. Pinter-Brown, Sonali M. Smith, Andrei R. Shustov, Kerry J. Savage & Julie M. Vose. (2016) A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British Journal of Haematology 172:4, pages 535-544.
Crossref
Crossref
E. S. Nesterova, S. K. Kravchenko, Ya. K. Mangasarova, E. A. Baryakh, A. E. Misyurina, V. I. Vorobyev, L. V. Plastinina, N. G. Chernova, A. M. Kovrigina, T. N. Obukhova, G. A. Klyasova, A. A. Shevelev, I. E. Kostina, E. G. Gemdzhian, T. V. Gaponova & A. I. Vorobyev. (2016) Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia. Terapevticheskii arkhiv 88:7, pages 62.
Crossref
Crossref
Marco Foppoli & Andrés J. M. Ferreri. (2014) Gamma‐delta t‐cell lymphomas. European Journal of Haematology 94:3, pages 206-218.
Crossref
Crossref
Dipti Gupta, Nandini Yadav, Frank Evans & Richard M. Steingart. (2014) Chemotherapy-Induced Cardiomyopathy in the Elderly. Current Cardiovascular Risk Reports 8:12.
Crossref
Crossref
Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Stefano A Pileri & Pier Luigi Zinzani. (2014) Past, present and future treatment strategies in peripheral T-cell lymphomas. International Journal of Hematologic Oncology 3:4, pages 299-311.
Crossref
Crossref
Andrew M. Intlekofer & Anas Younes. (2014) From empiric to mechanism-based therapy for peripheral T cell lymphoma. International Journal of Hematology 99:3, pages 249-262.
Crossref
Crossref
Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2014) CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma. PLoS ONE 9:1, pages e87066.
Crossref
Crossref
Nishitha M. Reddy & Andrew M. Evens. (2014) Chemotherapeutic Advancements in Peripheral T-Cell Lymphoma. Seminars in Hematology 51:1, pages 17-24.
Crossref
Crossref
Mehdi Hamadani, Sarah M. Abu Kar, Saad Z. Usmani, Bipin N. Savani, Ernesto Ayala & Mohamed A. Kharfan-Dabaja. (2014) Management of Relapses After Hematopoietic Cell Transplantation in T-Cell Non-Hodgkin Lymphomas. Seminars in Hematology 51:1, pages 73-86.
Crossref
Crossref
Koppany Visnyei, Michael L. Grossbard & Ilan Shapira. (2013) Hepatosplenic γδ T-cell Lymphoma: An Overview. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 360-369.
Crossref
Crossref